http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-20023785-U1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42a59c5faed1d0699d86edc5a2eee671
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
filingDate 2000-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-20023785-U1
titleOfInvention Therapeutic with a botulinum neurotoxin
abstract usenthe botulinum neurotoxins of Clostridium botulinum type A,nB, C, D, E, F, or G, or a mixture of two or more of these neurotoxins,ncharacterized in that the neurotoxin or the mixture ofnNeurotoxins are free from the complexing proteins that are onnnaturalnTo form complexes with the botulinum neurotoxins, for the productionna pharmaceutical for the treatment of dystonia or diseasesnof the nervous system in animal or human patientsnalready neutralizing antibodiesnagainst botulinum neurotoxin complexes.
priorityDate 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449115571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23690444

Total number of triples: 20.